Risk factors for coexistence of cervical elongation in uterine prolapse.

08:00 EDT 8th August 2018 | BioPortfolio

Summary of "Risk factors for coexistence of cervical elongation in uterine prolapse."

To identify factors predicting cervical elongation in women with uterine prolapse.


Journal Details

This article was published in the following journal.

Name: European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Pages: 94-97


DeepDyve research library

PubMed Articles [21269 Associated PubMed Articles listed on BioPortfolio]

Risk factors for the failure of iliococcygeus suspension for uterine prolapse.

The objective of this study was to evaluate the risk factors for the failure of iliococcygeus suspension (ICG) for uterine prolapse and estimate its long-term success rates using a clinically relevant...

The prognostic factors influencing overall survival in uterine cervical cancer with brain metastasis.

The occurrence of brain metastasis (BM) has increased due to improved overall survival (OS) in uterine cervical cancer. However, research about prognostic factors and therapeutic guidelines for BM in ...

Uterine and Cervical Cancer with Irreducible Pelvic Organ Prolapse.

Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: A population based study in Tanzanian rural community.

The prevalence and risk-factors of pelvic organ prolapse (POP) in Tanzania are unknown. To help elucidate the problem, we assessed POP and associated risk-factors among Tanzanian women by deploying th...

Acute kidney failure due to uterine prolapse.

Kidney failure due to uterine prolapse is rare, nonetheless, early recognition and treatment of this form of postrenal kidney failure are essential in order to prevent serious complications.

Clinical Trials [8936 Associated Clinical Trials listed on BioPortfolio]

Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse

The purpose of this study is to determine the long term performance of Restorelle system for the treatment of uterine prolapse.

The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse

The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the t...

The Effect of Pessary Post Vaginal Prolapse Repair, for One Month, to Reduce the Recurrence Rate of Prolapse

Genital prolapse is a common complain. 30-40% of women will complain of uterine prolapse or cystocele or rectocele, or mixed. About half of them will require surgical repair for the prolap...

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

RATIONALE: Determining how patients make decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are s...

Optimal Catheter Placement During Sonohysterography: Comparison of Cervical to Uterine Placement

The primary objective of this investigation was to evaluate if the location of placement of the SIS balloon into either the uterine cavity or the cervical canal affected discomfort perceiv...

Medical and Biotech [MESH] Definitions

Incompetent UTERINE CERVIX is usually diagnosed in the second trimester of PREGNANCY. It is characterized by passive painless cervical dilation in the absence of UTERINE CONTRACTION; BLEEDING; INFECTION; and sometimes with the amniotic sac (AMNIOTIC MEMBRANE) bulging through the partially dilated cervix. Left untreated, this condition may lead to premature pregnancy loss, such as HABITUAL ABORTION.

Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.

Factors that utilize energy from the hydrolysis of GTP to GDP for peptide chain elongation. EC 3.6.1.-.

A parameter usually used in PRENATAL ULTRASONOGRAPHY to measure the length of the uterine neck (CERVIX UTERI). Cervical length or its shortening is used to identify and prevent early cervical opening and PRETERM BIRTH.

Protein factors uniquely required during the elongation phase of protein synthesis.

Quick Search


DeepDyve research library

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Searches Linking to this Article